Company intelligence / Profile preview

BIOCORNEUM

Marlton, New Jersey, United States
Ownership
Private
Development stage
Other
01

Overview

BIOCORNEUM is a leading professional-grade silicone scar treatment brand, widely recognized within the plastic surgery and dermatology communities. The product line utilizes a patented cross-linking silicone gel technology known as Silishield, which creates a protective, breathable, and waterproof environment to optimize the healing of scars. It is distinguished as the first silicone scar gel to incorporate FDA-accepted SPF 30, which helps prevent UV-induced hyperpigmentation in newly formed scar tissue. Originally developed by Enaltus and later owned by Sientra, the brand was acquired by Tiger BioSciences in 2024 following Sientra's restructuring. BIOCORNEUM is clinically proven to flatten, soften, and reduce the redness of scars resulting from surgical procedures, injuries, and burns. The brand remains a gold standard in post-operative scar management for aesthetic and reconstructive surgery.

Therapeutic areas
Dermatology
Modalities
DeviceTopical gelSilicone-based therapy
Industry
Consumable Medical Devices

Beyond the preview

Go deeper on BIOCORNEUM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOCORNEUM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call